Use of a gonadotropin-releasing hormone antagonist for endometrial maturation and synchronization in an ovum recipient
Case report
OA: closed
CC0
AI-generated summary
This study investigated the efficacy of a GnRH antagonist in synchronizing endometrial maturation for ovum recipients undergoing embryo transfer.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
OBJECTIVE: To report the novel use of hMG and the GnRH antagonist for endometrial preparation and synchronization in a woman participating in an ovum donation program who was resistant to endometrial preparation with estrogen replacement.
DESIGN: Case report.
SETTING: Tertiary fertility center.
PATIENT(S): The patient had inadequate endometrial maturation, as determined by pelvic ultrasound (thickness of <5 mm), after estrogen replacement. Ovarian hyperstimulation with hMG and a GnRH antagonist resulted in an endometrial thickness of 7.5 mm. Synchronization with a ovum donor resulted in a delivered twin gestation.
INTERVENTION(S): : Late follicular transvaginal ultrasound.
MAIN OUTCOME MEASURE(S): Appropriate endometrial maturation and pregnancy.
RESULT(S): Appropriate endometrial maturation.
CONCLUSION(S): For women with inadequate endometrial maturation with simple estrogen replacement, ovarian hyperstimulation with hMG and a GnRH antagonist can yield appropriate endometrial maturation for pregnancy through ovum donation.
My notes (saved in your browser only)
MeSH descriptors
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cites (1)
References (4)
- Vaginal sildenafil (Viagra): a preliminary report of a novel method to improve uterine artery blood flow and endometrial development in patients undergoing IVF via openalex
- doi:10.1016/s0015-0282(16)54069-2 via openalex
- doi:10.1016/s0015-0282(16)58504-5 via openalex
- doi:10.1016/s0015-0282(98)00294-5 via openalex
Source provenance
- openalex
- last seen: 2026-05-11T06:09:19.794676+00:00
- pubmed
- last seen: 2026-10-08T21:02:12.072533+00:00
- unpaywall
- last seen: 2026-09-17T06:32:46.214484+00:00
License: CC0
· commercial use OK